Regeneron Pharmaceuticals said on Monday its experimental gene therapy showed improved hearing in 10 of 11 children between ...
Regeneron’s gene therapy, dubbed DB-OTO, is a cell-selective AAV gene therapy for children with hearing loss stemming from a ...
Ten of 11 children born with a rare form of congenital hearing loss experienced improvements after receiving the company’s ...
Thousands of families are waiting to access services – we would like to reflect your stories in a forthcoming article.
Lindsay Gibson's "Adult Children of Emotionally Immature Parents" has become something of a cult classic, with over one ...
According to a systematic review and meta-analysis of 41 randomized clinical trials, involving nearly 5,000 children, NSAIDs, ...
Regeneron's DB-OTO gene therapy shows improved hearing in 10 of 11 children in the CHORD trial, with three reaching ...
5h
Cedar Rapids KCRG-TV on MSNChildServe offers new program to help second graders and up with readingChildServe works to help young children with special health care needs, as part of that mission they’re helping students with ...
6d
News Medical on MSNPromising results from first prenatal therapy for spinal muscular atrophySpinal muscular atrophy (SMA) is a progressive neurodegenerative disorder set in motion before birth. Scientists at St. Jude ...
Ten out of 11 children with a form of congenital deafness who were treated with an experimental gene therapy developed by ...
As presented at ARO, 10 of 11 children with at least one post-treatment assessment showed notable improvements in hearingSpeech and development ...
In Regeneron Pharmaceuticals Inc.’s phase I/II Chord study of 12 children with genetic hearing loss tied to the variants of the otoferlin gene, 10 out of 11 have showed notable improvements in their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results